In 2016, He et al. studied the mechanisms of mTOR inhibitor antitumor activity in CRC cells and xenografts and demonstrated the proapoptotic activity and an essential role of death receptor‐mediated apoptosis on inhibition of 4E‐BP1 phosphorylation.33 Here, MTOR is linked to colorectal carcinoma.